Delivery Order SPE2DB20D7061-SPE2DB24FSPZ7
Award Date
9/27/24
Potential Completion Date
9/30/24
Potential Value
$28K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ciprofloxacin-Dexamethasone Otic Suspension, a pharmaceutical product used for the treatment of ear infections. The contract has a ceiling value of $7,019.94 and a completion date of April 25, 2024. This award is part of a larger Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ciprofloxacin-Dexamethasone Otic Suspension, a medication used to treat ear infections. The contract has a ceiling value of $2,354.89 and runs through July 18, 2023. It is a firm-fixed-price contract type. The contract was not designated with any set-aside requirements, indicating open competition. AmerisourceBergen holds a...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply Ciprofloxacin-Dexamethasone otic suspension (7.5 mL) for a ceiling value of $1,165.68. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential total value of $999,999,999.00 and a performance period through December 31,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ciproflox-Dexameth Otic Suspension, a topical ear medication. The $1,115.45 delivery order contract has a completion date of September 11, 2024 and is classified as a firm fixed price contract. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies to provide a wide range of...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical with an ultimate completion date of October 18, 2023. The $1,389.82 firm fixed-price delivery order is for Ciprofloxacin-Dexamethasone Otic Suspension, a specialized pharmaceutical product. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ciprofloxacin-Dexamethasone Otic Suspension, a specialty medication used to treat ear infections. The $1,427.02 firm fixed-price contract has a completion date of December 22, 2022. It is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,297.69 firm fixed-price delivery order is for the supply of Ciprofloxacin-Dexamethasone Otic Suspension, a pharmaceutical product used to treat ear infections. The contract has an ultimate completion date of July 12, 2024 and does not utilize a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ciprofloxacin-Dexamethasone Otic Suspension 7.5 ML, a specialty pharmaceutical product, with a ceiling value of $2,440.72. The contract has an ultimate completion date of March 8, 2024 and is a Firm Fixed Price Delivery Order. This award is not designated as a set-aside contract....
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, involves the delivery of Ciprofloxacin-Dexamethasone Otic Suspension, a prescription medication, to the Defense Logistics Agency (DLA) Troop Support Medical. The $7,449.27 firm-fixed-price delivery order was issued on August 30, 2024, with a completion date of September 3, 2024. The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,369.59, is for the delivery of Ciprofloxacin-Dexamethasone Otic Suspension, a pharmaceutical product used to treat certain ear infections. The contract has a period of performance through July 12, 2024 and is a Firm Fixed Price contract type. There is no set-aside designation for this...